Young Min Kwon (Young M Kwon, Young Kwon)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Topics

Acute Ischemic Stroke

Top Venues

BioImpacts : BI

Expert review of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Nazanin Kianinejad, Young Min Kwon
Dual-targeting of brain tumors with nanovesicles. BioImpacts : BI 13 (1) (2022)
Wael A Mahdi, Mohammad S Absar, Suna Choi, Victor C Yang, Young Min Kwon
Enhanced control of bioactivity of tissue plasminogen activator (tPA) through domain-directed enzymatic oxidation of terminal galactose. BioImpacts : BI 12 (6) (2022)
Nazanin Kianinejad, Young Min Kwon
Dual-targeting of brain tumors with nanovesicles. BioImpacts : BI 13 (1) (2022)
Wael A Mahdi, Mohammad S Absar, Suna Choi, Victor C Yang, Young Min Kwon
Enhanced control of bioactivity of tissue plasminogen activator (tPA) through domain-directed enzymatic oxidation of terminal galactose. BioImpacts : BI 12 (6) (2022)
Yadollah Omidi, Nazanin Kianinejad, Young Min Kwon, Hossein Omidian
Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier. Expert review of clinical pharmacology 14 (3) (2021)
Young Min Kwon
Targeted delivery of thrombolytic enzymes. BioImpacts : BI 11 (2) (2020)
Muhammad Hadi Sultan, Wael A Mahdi, Young Min Kwon
Pluronic® F127-mediated control of insulin release rates from NPH microcrystals and blood glucose depression in STZ-induced diabetic rats. BioImpacts : BI 11 (1) (2020)